Medical Weight Loss for Melbourne, Florida Residents

Melbourne, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Melbourne through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Melbourne: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Florida. Results vary. Doctor review just $119 (medication separate).

Why Melbourne Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Melbourne is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Florida trust us to guide a serious decision about their health.

Melbourne patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

Patients in Melbourne get the identical physician-supervised treatment that someone walking into our Costa Mesa office would get, all of it handled by telehealth so Florida residents never have to travel. We care for patients throughout downtown Melbourne and the Space Coast of Brevard County. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Melbourne patient.

Distance simply stops mattering here, since every appointment for Melbourne residents takes place over secure video rather than in a waiting room. We accept HSA and FSA cards for the $119 physician review, which lets many Melbourne patients use pre-tax dollars toward their care. Florida is one of the most populous states in the nation, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Melbourne telehealth visits.

How Telehealth Works for Melbourne

The path from curious to treated is short, and it all runs through your screen. People in Melbourne start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Melbourne home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Melbourne

Is there a New Hope Weight Loss clinic near Melbourne?

Our physical clinic is in Costa Mesa, California, and we care for patients in Melbourne, Florida entirely by telehealth. You do not need a local office to start. Dr. Anjmun Sharma reviews your history and goals during a secure video consult, and your eligibility for a compounded GLP-1 program is confirmed there.

Do I have to travel to Costa Mesa from Melbourne for treatment?

No. Everything happens online, so Melbourne patients never drive to California. Your consult, follow-ups, and messaging run through a private portal. If you are approved, compounded semaglutide or tirzepatide ships straight to your Melbourne address in temperature-controlled cold-pack packaging to keep it stable in transit.

What does treatment cost for someone in Melbourne?

The physician review is $119. Compounded semaglutide starts at $166 a month, or $499 for the 90-day program, and tirzepatide starts at $233 a month. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, and there is no distance surcharge for Melbourne patients.

What areas of Melbourne do you serve?

We serve patients from across Melbourne by telehealth, including downtown Melbourne and the Space Coast of Brevard County.

Is my health information private as a Melbourne patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Melbourne patients get the same confidentiality as any telehealth patient.

Melbourne Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Melbourne, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.